majoo is an Indonesian software-as-a-service company that gives micro, small and medium enterprises (MSMEs/UMKM) an all-in-one cloud platform combining a point-of-sale cashier, inventory, accounting, employee management, CRM, business analytics and an owner app. Founded in Jakarta in 2019, it lets small merchants in food & beverage, retail, services and beauty run and grow their businesses from a single dashboard and sell across offline and online channels.
Thenuka Karunaratne is the CEO and co-founder of daydream, a San Francisco startup building an AI-native agency for organic search that pairs SEO agents with human growth experts. He started making money from affiliate websites in high school, bootstrapped a streaming-search business called Flixed through college using programmatic SEO, and in September 2023 launched daydream with co-founder Shravan Rajinikanth. The company raised a $15M Series A in April 2026 led by WndrCo, bringing total funding to roughly $21M.
Tony Holdstock-Brown is the co-founder and CEO of Inngest, a San Francisco developer platform that gives engineers a durable, observable execution layer for background jobs, workflows, and AI agents. A self-described tinkerer since age 10 and former Docker engineer, he started Inngest in 2021 with CTO Dan Farrelly after the two met in a New York co-working space. The company has raised roughly $31.6M, including a $21M Series A led by Altimeter in 2025, on the thesis that in an AI era the real moat is how fast a team can iterate.
Clerq is a New York-based fintech building an account-to-account (A2A) bank payments platform for high-ticket transactions. It lets merchants - starting with automotive and powersports dealerships - accept low-cost, guaranteed payments pulled directly from a customer's bank account, with card-like ease and no chargeback, fraud, or funding risk. Founded in 2022 by former Citadel and JP Morgan investors Truett Dwyer and Ben Markowitz, Clerq raised a $12M Series A led by 645 Ventures in October 2025, bringing total funding to roughly $21M.
Equal Parts is an Austin-based insurance company that acquires established independent insurance agencies and equips them with shared infrastructure and AI-driven automation. Founded in March 2025 by Mike Witte, Graham Yennie and Mike Meller, it positions itself as a growth network - preserving each agency's identity and local relationships while standardizing back-office workflows so agents can focus on clients. The company raised a $23M Series A led by Inspired Capital in February 2026 and aims to become a top-5 insurance distributor by acquiring 25 agencies in 2026 and reaching $1B in premiums.
Fount Bio is a Somerville, Massachusetts life-science company that builds long-lasting hyaluronic acid (HA) matrices directly inside living tissue. Its proprietary Flī-HA platform uses Nobel-Prize-winning bioorthogonal (click) chemistry to deliver HA building blocks that self-assemble in situ into a biostable, high-molecular-weight matrix - overcoming the delivery and degradation barriers that have long forced HA to be injected as pre-formed filler. The lead product, Flī-Derm, is a needle-free liquid for aesthetic dermatology that reduced fine lines and wrinkles in a blinded clinical study and won IMCAS 2024's Innovation of the Year. The tunable platform extends toward ophthalmology, joints, mucosal tissue and women's health.
PIC Therapeutics is a Natick, Massachusetts biotechnology company developing small-molecule precision medicines that target cancer at the level of protein translation. Rather than chasing individual oncogenes one at a time, PIC modulates the Pre-Initiation Complex (PIC) and the translation factor eIF4E - a convergence point for many oncogenic signaling pathways - to selectively shut down the production of cancer-driving proteins while sparing healthy cells. Founded on the research of Harvard structural biologist Gerhard Wagner and led by CEO Katherine Bowdish, the company is advancing an allosteric eIF4E modulator toward first-in-human studies in drug-resistant metastatic breast cancer, backed by a $35M Series A led by OrbiMed.
PranaX is a Houston-based regenerative medicine biotechnology company developing stem cell-derived exosome products to counter aging, inflammation, and tissue damage. Built on exosome technology exclusively licensed from The University of Texas MD Anderson Cancer Center, PranaX operates an FDA-registered cGMP facility at the Levit Green life science campus and is bringing to market a physician-directed exosome wellness supplement (ExoWELL) and a personal exosome banking service (ExoSTORE). The company closed an oversubscribed $17M Series A in early 2026.
Stuf is a New York-based, tech-enabled self-storage company that partners with commercial and multifamily real estate owners to convert underused space - basements, garages, mechanical floors, vacant retail - into remotely managed, hospitality-inspired storage for the people and businesses nearby. Founded in 2020 by CEO Katharine Lau, Stuf runs a lean, app-driven operation across dense urban markets and shares revenue with landlord partners rather than owning or building traditional storage facilities.

Mehul Bhatt is co-founder and CEO of FloCareer, an interview-as-a-service HR tech platform that dispatches expert freelance interviewers (plus AI proctoring) to run structured technical screens for enterprises. A former Cisco solutions architect with a Master's from Illinois Institute of Technology, he spent 16 years as an individual contributor before starting the company with Mohit Jain. FloCareer raised a $5.7M Series A in October 2021 and has conducted more than one million interviews for 600+ clients across the US and India.
Convey is a San Francisco AI workforce platform that lets non-technical operators build, train, and manage "digital teammates" - AI workers that take over repetitive operational tasks like invoice processing, financial reconciliation, and campaign reporting without any engineering. Founded in 2025 by former DoorDash early engineer Rohan Chopra with Stanford friends Will Harvey and Diego Canales, Convey raised a $38M Series A led by Andreessen Horowitz in June 2026 and says it has completed more than one million hours of real work for enterprises including NBCUniversal, Unity, Samsara, and Faire.
NEOK Bio is a Palo Alto-based clinical-stage biotechnology company developing bispecific antibody drug conjugates (ADCs) for solid tumors. Founded and led by physician-executive Mayank Gandhi and backed by Korean antibody specialist ABL Bio, NEOK launched from stealth in November 2025 with a $75 million Series A. Its dual-targeting approach binds two complementary tumor antigens at once, aiming to widen the therapeutic window and overcome the resistance and toxicity limits of conventional single-target ADCs. The company's two lead programs, NEOK001 (ROR1/B7-H3) and NEOK002 (EGFR/MUC1), both cleared FDA IND review in early 2026 and are headed into Phase 1 studies.
Redrob is an AI company building large language models and go-to-market tools for sales, recruitment, and prospecting. Its platform combines a 700M+ contact data pool, verified emails, and real-time buying signals to help B2B teams find prospects, automate outreach, and screen talent. Founded by former international lawyer Felix Kim, Redrob positions itself as an affordable, enterprise-grade AI stack for emerging markets and cost-conscious companies, and aims to become one of the world's most-used LLM platforms by 2028.
Marlon Misra is the cofounder and CEO of Assembly (formerly Copilot), a Y Combinator-backed New York software company building a client-portal platform - often described as 'Shopify for service businesses.' Assembly raised a $10M Series A, serves more than 1,000 firms and roughly a million of their clients, and rebranded from Copilot in September 2025 alongside the launch of an AI assistant for professional services firms.
Matt Kennedy is co-founder and CEO of Mantra Health, a New York-based digital mental health company that partners with over 150 college and university campuses to deliver telepsychiatry, teletherapy and campus-wide wellness programs to more than 1.3 million students. He moved from COO to CEO in 2023, and leads a team of roughly 130 employees and 100+ in-house clinicians.
Mike Shebat is the co-founder and CEO of Traba, a New York-based labor marketplace that supplies vetted on-demand workers to warehouses, distribution centers, and light industrial employers. He started the company in 2021 after seeing, from inside a McMaster-Carr shipping floor and later Uber Eats, how often temp workers simply don't show up. Traba has raised roughly $46 million from Founders Fund and Khosla Ventures, and Shebat, a Forbes 30 Under 30 honoree, runs it on a famously intense in-office schedule.
Patrick Anderson is Co-Founder and CTO of Moab, a New York based startup building a modern operating system for equipment rental and dealership businesses. He was previously Head of Core Engineering at Ramp, joining the fintech as its 11th employee. In February 2026 Moab emerged from stealth with $16M in combined Seed and Series A funding backed by Elad Gil and Ironspring Ventures.

Rob Hayden is the CEO and co-founder of Renew, a New York based AI powered retention platform for multifamily and single family rental operators. He co-founded the company in 2021 with Kevin Murphy after both worked together at rental insurance startup Jetty. In October 2025 Renew closed a $12 million Series A led by Haymaker Ventures with participation from Goldcrest Capital and Upfront Ventures, bringing total funding to roughly $20 million and financing the launch of the industry's first Resident Referral Network.
Robert Brennan is co-founder and CEO of All Hands AI, the company behind OpenHands, an MIT-licensed open source platform for AI coding agents that started life in 2024 as an OpenDevin fork built in 24 hours after Cognition's Devin demo. A former Google search engineer who patented an answer-extraction algorithm shipped inside Google Search in 2013, Brennan later founded DataFire and led open source at Fairwinds before helping launch OpenHands with Xingyao Wang and Graham Neubig. The company has raised roughly $23.8M total across a $5M Menlo-led seed and an $18.8M Series A led by Madrona in November 2025.

Romaric Philogène is the CEO and co-founder of Qovery, a platform-engineering company that turns cloud infrastructure into a self-service experience for developers. A former site reliability engineer with a decade in ad-tech and financial systems, he started Qovery in 2019 with Pierre Mavro and Morgan Perry and, in September 2025, raised a $13M Series A led by IRIS and Crane Venture Partners, with angel checks from Datadog's Olivier Pomel and Alexis Lê-Quôc.
Stefan Bauer is the co-founder and CEO of Marker Learning, a New York City telehealth company that connects families and schools with licensed psychologists for learning disability evaluations, cutting the traditional cost and turnaround time of assessments. A Yale School of Management MBA and former McKinsey and Morgan Stanley professional, Bauer co-founded the company with Emily Yudofsky in 2021; it has since raised $19.7 million in total funding, including a $15 million Series A led by Andreessen Horowitz in 2023.
Applied Carbon (formerly Climate Robotics) builds tractor-pulled machines that turn crop residue into biochar in a single pass across the field. The Houston-based startup converts post-harvest plant waste into a stable form of carbon that improves soil health and locks CO2 underground for centuries, selling carbon removal credits to buyers including Microsoft.
Fulcrum is a San Francisco AI platform that automates the unglamorous backbone of insurance brokerages - policy checking, proposal generation, certificate issuance and carrier sales prep - so account managers can scale their books of business without scaling headcount. Founded in 2023 by Arjun Mangla and Sambhav Anand, it raised $25M in combined Seed and Series A led by CRV in January 2026 and is in use at nearly half of the top 50 U.S. brokerages.
Impart Security is a San Francisco cybersecurity company building a unified runtime protection platform for AI, APIs, and web applications. Founded in 2020 by Signal Sciences veterans Jonathan DiVincenzo, Marc Harrison, and Brian Joe, the company merges WAF, API security, Cloud Application Detection & Response, and AI Runtime Protection into one engine that runs autonomous defense agents inside production traffic.
Kimia Therapeutics is a Berkeley-based biotech building ATLAS, a drug-discovery platform that pairs nanoliter-scale high-throughput precision chemistry with machine learning and genome editing to map the druggable space at single-atom resolution. Spun out of Carmot Therapeutics in 2023 and backed by $55M in Series A funding, Kimia is using its chemical atlas to advance therapeutic programs in cancer and immunology.
Kolena is a San Francisco-based AI company building software that automates document-heavy workflows for regulated industries - real estate, insurance, banking, and financial services. Founded in 2021 by Mohamed Elgendy, Andrew Shi, and Gordon Hart, the company began as a rigorous ML model testing platform and has since extended that quality-first DNA into agentic document workflow automation, with an emphasis on transparency, citations, and auditability.
Mandolin is a San Francisco healthcare AI company building agents that handle the paperwork blocking patients from specialty drugs. Its software automates intake, benefits verification, prior authorization, and claims work for infusion providers, specialty pharmacies, and health systems - the back office that decides how quickly a cancer or Alzheimer's patient actually gets treated.
Paxton AI is an all-in-one generative AI assistant built for lawyers. It handles legal research, document drafting, contract review, and mass document analysis across U.S. federal and state law, with a published 94% non-hallucination rate benchmarked against Stanford research. Founded in 2023 by Tanguy Chau and Michael Ulin, the company is based in Palo Alto and has raised $28M total, including a $22M Series A led by Unusual Ventures in January 2025.
Cajal Therapeutics (originally launched as Cajal Neuroscience) is a Seattle biotechnology company developing novel medicines to restore biological homeostasis, with a focus on neurodegenerative diseases, anemias of inflammation, and iron-related disorders. Built on a platform that pairs integrative human genetics, high-throughput functional genomics, and industrialized whole-brain imaging with deep neuroscience expertise, the company aims to systematically validate disease targets at unprecedented scale and translate them into small molecule and RNA therapeutics. It launched in November 2022 with a $96 million Series A and counts a roster of celebrated neuroscientists among its co-founders.
Delphia Therapeutics is a Cambridge, Massachusetts biotech pioneering a new field of cancer biology it calls activation lethality - the idea that cancer cells with oncogenic mutations live dangerously close to the upper limit of how much pathway activity they can tolerate, and can be pushed past it. Rather than blocking cancer signals like most drugs, Delphia designs targeted activators that overload cancer's stress pathways until the cell dies, aiming for durable benefit and a way around drug resistance. Founded in 2024 by Kevin Marks, Bill Sellers and Mike Dillon, it launched with a $67 million Series A led by GV, Nextech Invest, Polaris Innovation Fund and Alexandria Venture Investments.